← Leaderboards
Tage Honore
Aestus Therapeutics, Inc.
$3,854,740
Attributed
$5,419,515
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,419,515 · 2
By mechanism
U01$3,129,550 · 1
R44$2,289,965 · 1
Top collaborators
- Thota Ganesh2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposDrug DiscoveryDrug KineticsTherapeutic AgentsGrantDosePharmaceutical PreparationsLeadResponseAcutePlasmaSafetyFutureAnimal ModelAnalgesicsAge MonthsAmyloid Beta-ProteinBiological AvailabilityAmyloidAdverse EventBaseAttenuatedAmericanArea
Grant awards (4)
Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease$1,392,306
U01 · FY2025 · AG
Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease$1,737,244
U01 · FY2024 · AG
Accelerated Discovery and Development of New Pain Therapeutics$1,308,367
R44 · FY2011 · NS · contact PI
Accelerated Discovery and Development of New Pain Therapeutics$981,598
R44 · FY2010 · NS · contact PI